A Phase I study of induction chemotherapy with S-1 and Cisplatin plus intraperitoneal administration of Docetaxel for gastric cancer with peritoneal dissemination.
Phase of Trial: Phase I
Latest Information Update: 16 Dec 2015
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 15 Dec 2015 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 09 Jan 2010 New trial record